Amporin Pharmaceuticals AG is a Swiss biotechnology company founded in Basel in 2024. The firm focuses on developing a new class of small-molecule drugs designed to target toxic…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Amporin Pharmaceuticals →Already a subscriber? Sign in
Xcout Intel tracks Amporin Pharmaceuticals continuously — this profile deepens as new filings, funding, people and hiring data arrive.